SeaCrest Wealth Management LLC cut its stake in Clover Health Investments, Corp. (NASDAQ:CLOV – Free Report) by 15.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 43,100 shares of the company’s stock after selling 7,800 shares during the quarter. SeaCrest Wealth Management LLC’s holdings in Clover Health Investments were worth $122,000 at the end of the most recent reporting period.
Several other hedge funds have also bought and sold shares of the stock. Viewpoint Capital Management LLC boosted its position in Clover Health Investments by 96.8% during the second quarter. Viewpoint Capital Management LLC now owns 30,500 shares of the company’s stock worth $38,000 after purchasing an additional 15,000 shares in the last quarter. Jaffetilchin Investment Partners LLC increased its stake in Clover Health Investments by 30.2% during the 1st quarter. Jaffetilchin Investment Partners LLC now owns 49,741 shares of the company’s stock worth $39,000 after buying an additional 11,550 shares in the last quarter. Vanguard Personalized Indexing Management LLC raised its stake in Clover Health Investments by 54.4% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 34,372 shares of the company’s stock valued at $42,000 after purchasing an additional 12,104 shares during the last quarter. Marshall Wace LLP purchased a new stake in shares of Clover Health Investments during the second quarter worth $55,000. Finally, Allspring Global Investments Holdings LLC raised its position in shares of Clover Health Investments by 151.2% in the first quarter. Allspring Global Investments Holdings LLC now owns 77,948 shares of the company’s stock valued at $62,000 after buying an additional 46,912 shares during the last quarter. Hedge funds and other institutional investors own 19.77% of the company’s stock.
Clover Health Investments Price Performance
CLOV stock opened at $4.00 on Friday. Clover Health Investments, Corp. has a 1 year low of $0.61 and a 1 year high of $4.71. The firm has a market capitalization of $1.99 billion, a PE ratio of -11.76 and a beta of 2.13. The business has a 50 day simple moving average of $3.14 and a 200-day simple moving average of $1.83.
Wall Street Analyst Weigh In
Separately, UBS Group assumed coverage on shares of Clover Health Investments in a research report on Monday, October 7th. They set a “neutral” rating and a $4.00 price target on the stock.
View Our Latest Analysis on CLOV
Clover Health Investments Company Profile
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
Featured Articles
- Five stocks we like better than Clover Health Investments
- 3 REITs to Buy and Hold for the Long Term
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- How to Calculate Inflation Rate
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
- Using the MarketBeat Stock Split Calculator
- MarketBeat Week in Review – 10/14 – 10/18
Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.